1986 Fiscal Year Final Research Report Summary
RELATIONSHIP BETWEEN PREDNISOLONE THERAPY AND OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS TYPE B
Project/Area Number |
60480212
|
Research Category |
Grant-in-Aid for General Scientific Research (B)
|
Allocation Type | Single-year Grants |
Research Field |
Gastroenterology
|
Research Institution | EHIME UNIVERSITY |
Principal Investigator |
OHTA YASUYUKI EHIME UNIVERSITY, PROFESSOR, 医学部, 教授 (40033055)
|
Co-Investigator(Kenkyū-buntansha) |
HORIIKE NORIO EHIME UNIVERSITY, ASSISTANT, 医学部, 助手 (90173624)
ONJI MORIKAZU EHIME UNIVERSITY, LECTURER, 医学部附属病院, 講師 (10112260)
|
Project Period (FY) |
1985 – 1986
|
Keywords | Hepatitis B Virus DNA / Prednisolone / Chronic Hepatitis Type B / HBV-DNAの肝細胞核内への組込み |
Research Abstract |
IN ORDER TO CLARIGY THE INTEGRATION OF HEPATITIS B VIRUS (HBV-DNA) INTO THE LIVER CELL DNA AND REPLICATION OF HBV FOLLOWING ADMINISTRATION OF GLUCOCORTICOID(PREDNISOLONE, PSL), WE INVESTIGATED THE CHANGE OF HBV-DNA IN SERA AND LIVERS IN PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS TREATED WITH PSL. HBV-DNA IN SERA INCREASED FOLLOWING PSL ADMINISTRATION. THREE WEEKS AFTER PSL USE THE INCREASE OF HBV-DNA BECAME MAXIMUM AND THE INCREASED RATIO WAS 3.2 TIMES BEFORE THE TREATMENT. ALTHOUGH FREE HBV-DNA IN LIVERS INCREASED BY PSL, THE INTEGRATION OF HBV-DNA INTO LIVER CELL DNA WAS NOT NEWLY DETECTED. PSL PROGRESS THE REPLICATION OF HBV TEMPORALLY, BUT IT WAS NOT INCREASE THE INTEGRATION OF HBV-DNA INTO LIVER CELL DNA, SO THE RISK OF CANCER OCCURENCE MAY BE LITTLE OR NONE.
|
Research Products
(10 results)